Learn more

HORMOS NUTRACEUTICAL OY LTD

Overview
  • Total Patents
    53
About

HORMOS NUTRACEUTICAL OY LTD has a total of 53 patent applications. Its first patent ever was published in 1999. It filed its patents most often in Australia, Finland and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, foods and drinks and organic fine chemistry are UMEZAWA KAZUO, NOVOGEN RES PTY LTD and ALIZYME THERAPEUTICS LTD.

Patent filings per year

Chart showing HORMOS NUTRACEUTICAL OY LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Ahotupa Markku 24
#2 Kangas Lauri 22
#3 Saarinen Niina 17
#4 Eckerman Christer 16
#5 Santti Risto 15
#6 Eklund Patrik 14
#7 Waerri Anni 10
#8 Unkila Mikko 10
#9 Korte Helena 9
#10 Maekelae Sari 9

Latest patents

Publication Filing date Title
WO2004000304A1 Lignan formulations
AU2003201621A1 Lignan derivatives
WO03061649A1 Method for prevention of diseases in coeliac patients
AU2003200836A1 Method for the preparation of matairesinol
AU2002338994A1 Method for the production of a phenolic substance from wood
FI20021545A0 Lignaanikomplekseja
FI20020563A0 Lignaanijohdannaisia
FI20020235A0 Process for the synthesis of vegetable lignan
FI20020222A0 Process for producing mammalian resin
FI20020223A0 A process for preparing a biologically active compound and a group of novel intermediates
FI20020088A0 Process for the preparation of vegetable lignans and a new intermediate
FI20020032A0 Preparation of matairesinol useful in nutritional supplement for treating e.g. cancer involves either catalytic hydrogenolysis of hydroxymatairesinol or reduction of hydroxymatairesinol by hydrogen transfer reaction
US7008666B2 Method of inhibiting overactivity of phagocytes or lymphocytes in an individual
US6689809B2 Food additive or product or a pharmaceutical preparation, comprising hydroxymatairesinol
US6271257B1 Decreasing the intracellular level of β-catenin by administering hydroxymatairesinol
US6451849B1 Use of hydroxymatairesinol for prevention of cancers, non-cancer, hormone dependent diseases and cardiovascular diseases by hydroxymatairesinol, and a pharmaceutical preparation, food additive and food product comprising hydroxymatairesinol